Increase Access to Medicines

We are proud to invest in innovation that solves the world's most significant health challenges. But we know that’s just the start of the conversation.

Our commitment to social impact inspires how we work to expand access to our medicines and tackle complex global health challenges.

We’re making care more affordable in the United States, like launching new programs so that anyone using Lilly insulin – regardless of their insurance status – is now eligible to fill their monthly prescription for $35. And we’re improving access to quality health care around the world, including our work to make our antibody therapies available to these low- and middle-income countries, furthering our goal of reaching as many patients with unmet needs as we can, no matter where they live.

Reaching across industry boundaries, we collaborate with leading partners to reach more people and help them feel better in their daily lives. Our collective work benefits individual patients and the entire global health system.

Lilly 30x30

Globally, we’ve established a goal – Lilly 30x30 – to improve access to quality health care for 30 million people living with limited resources, every year, by 2030. This is in addition to the more than 40 million people we currently reach annually through our medicines.

Lilly 30x30 is a company-wide effort and includes strategic collaborations with external partners, such as the Bill & Melinda Gates Foundation, and donations supporting nonprofit organizations, including the Lilly Foundation, the Lilly Cares Foundation and Life for a Child.

We use a mix of philanthropy and shared value-based approaches to improve health systems and concentrate on diseases where we have deep technical expertise, including diabetes, cancer and, now, COVID-19.

We focus our 30x30 efforts in three key areas:

Pipeline

Discovering medicines, repurposing internal assets and collaborating externally for diseases that disproportionately affect people in resource-limited settings

Programs

Strengthening and creating new programs that help improve access to Lilly medicines

Partnerships

Building partnerships that strengthen health systems, increase access to medicines and improve care

At Lilly, our purpose is to unite caring with discovery to create medicines that make life better for people around the world. Core to our purpose is our commitment to aid human suffering – independent of an individual’s or nation’s economic status – and to conduct our business in a responsible way for the long term.

David A. RicksChairman and CEO

2021 Updates: Lilly's Global COVID-19 Response

View Story

Equitable Access to Medicines in Low- and Middle-Income Countries

View Story

Life for a Child: Expanding Diabetes Care for Vulnerable Youth

View Story

Lilly Global Health: Diabetes Impact Project in Indianapolis

View Story